Journal article · 2026 · Open access

NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW

*1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. Tathe

World Journal of Pharmaceutical Research · Published 1 February 2026 · DOI 10.5281/zenodo.18426659

Read the free full textCite this paper

In brief

“NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW” is a 2026 journal article by *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. Tathe, published in World Journal of Pharmaceutical Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at World Journal of Pharmaceutical Research.

Citations
0
Authors
1

Abstract

The majority of new drug molecules discovered through high-throughput screening possess poor aqueous solubility, resulting in low oral bioavailability and limited clinical success. Nearly 40–70% of small-molecule drugs fall into Biopharmaceutics Classification System (BCS) Class II or IV, where solubility and dissolution are the rate-limiting steps in absorption. Nanocrystal technology has emerged as a simple yet powerful strategy to address these issues by reducing drug particles to the nanometer scale, thereby increasing surface area, dissolution velocity, and apparent saturation solubility. Unlike polymeric nanoparticles or lipid carriers, nanocrystals consist almost entirely of the pure active pharmaceutical ingredient stabilized by surfactants or polymers, offering high drug loading and improved performance. This review provides a comprehensive overview of nanocrystals as a drug delivery approach, discussing their theoretical basis, preparation methods, stabilizers, characterization techniques, pharmaceutical applications, marketed products, regulatory aspects, stability concerns, and future perspectives. Tables and figures are included to aid clarity.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026). NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659

MLA 9

Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW.” World Journal of Pharmaceutical Research, 2026. https://doi.org/10.5281/zenodo.18426659.

Chicago

Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. 2026. “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW.” World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659.

Harvard

Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026) ‘NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW’, World Journal of Pharmaceutical Research. doi:10.5281/zenodo.18426659.

IEEE

G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. Tathe, “NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW,” World Journal of Pharmaceutical Research, 2026, doi: 10.5281/zenodo.18426659.

BibTeX

@article{tathe2026nanocrystals,
  title     = {{NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW}},
  author    = {Tathe, *1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R.},
  journal   = {World Journal of Pharmaceutical Research},
  year      = {2026},
  doi       = {10.5281/zenodo.18426659},
  url       = {https://doi.org/10.5281/zenodo.18426659}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • nanocrystals
  • bioavailability enhancement
  • poorly water-soluble drugs
  • dissolution rate
  • oral bioavailability
  • BCS Class II and IV drugs
  • stabilizers
  • surfactants

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Tathe, G. D. P. H. S. N. M. S. N. A. K. K. S. S. G. D. H. D. P. R. (2026). NANOCRYSTALS AS A NOVEL PHARMACEUTICAL APPROACH FOR BIOAVAILABILITY ENHANCEMENT: A COMPREHENSIVE REVIEW. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.18426659

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at World Journal of Pharmaceutical Research.

Who wrote this paper?

*1Mr. Ganesh D. Parihar, 2Mr. Harshal S. Nage, 3Mr. Mukesh S. Naiknawre, 4Ms. Anuradha. K. Kendhale, 5Ms. Sakshi S. Ghuge, 6Mr. Devanand H. Dongre, 7Dr. Prafulla R. Tathe.

What is the DOI of this paper?

10.5281/zenodo.18426659. The permanent link is https://doi.org/10.5281/zenodo.18426659.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.